GlassScriptPhysician profile
Farrell Clifton Tyson
NPI 1508857491
$578,738.67
in general payments reported to CMS, 2019-2025
30 companies · $27K in 2025
The $27K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $40K · 2020: $125K · 2021: $134K · 2022: $112K · 2023: $70K · 2024: $72K · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $142K · Food and Beverage: $8,126 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,580 · Education: $5,446 · Travel and Lodging: $3,057 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,175 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $141,778.00 |
| Food and Beverage | $8,126.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,580.00 |
| Education | $5,445.90 |
| Travel and Lodging | $3,057.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,175.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Cataract Technology INC. | $295,204.02 | 2019-2024 | |
| Alcon Vision LLC | $146,443.76 | 2019-2025 | Clareon, Acrysof Iq Panoptix Uv Iol, Acrysof Iq Vivity |
| Rxsight INC | $37,971.73 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $35,069.61 | 2022-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Stellaris Elite |
| Alcon Research LLC | $21,300.00 | 2019-2024 | |
| Carl Zeiss Meditec, INC. | $18,615.15 | 2019-2024 | |
| Carl Zeiss Meditec USA, INC. | $9,997.41 | 2021-2025 | Quatera 700, Callisto Eye, Cirrus Hd-Oct |
| Carl Zeiss Meditec Ag | $6,000.00 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $1,428.05 | 2019-2025 | Tecnis Iol, Veritas Vision System, Tecnis Simplicity |
| Dutch Ophthalmic Research Center (International) B.V. | $1,339.85 | 2024 | Tissueblue, Eva, Combined Machine |
| Glaukos Corporation | $963.37 | 2019-2025 | Idosetr, Istent Infinite, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $715.23 | 2022-2025 | Durysta |
| Lensar, INC. | $666.61 | 2019-2025 | Lensar Laser System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $531.14 | 2019-2021 | |
| Dutch Ophthalmic, USA | $525.54 | 2023-2025 | Eva, Combined Machine, Tissueblue |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $455.29 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $315.42 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $240.38 | 2019-2021 | |
| Ivantis, INC | $217.04 | 2019-2021 | |
| Harrow Eye, LLC | $173.00 | 2024 | |
| Dompe US, INC. | $159.29 | 2023-2024 | Oxervate |
| Bausch Health US, LLC | $102.44 | 2019-2020 | |
| Carl Zeiss Meditec Production LLC | $69.03 | 2019 | |
| Rayner Intraocular Lenses Limited | $64.59 | 2022-2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Kala Pharmaceuticals, INC. | $53.08 | 2019-2022 | |
| Eyepoint US, INC. | $43.22 | 2020 | |
| Novartis Pharmaceuticals Corporation | $27.66 | 2023 | |
| Eyevance Pharmaceuticals LLC | $20.50 | 2019 | |
| Ocular Therapeutix, INC. | $19.31 | 2020 | |
| Lombart Brothers, INC. | $6.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$41,637.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farrell Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.